StonvexLoading…
StonvexStonvexStonvexCore line items from MSAI's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $5.55M | $7.40M | $5.43M | $7.27M |
Operating Income | $-12.01M | $-18.88M | $-21.48M | $-12.02M |
Net Income | $-11.71M | $-21.50M | $-22.27M | $-13.29M |
EPS (Diluted) | $-0.31 | $-1.07 | $-3.56 | $-2.51 |
Total Assets | $35.47M | $15.48M | $16.37M | $17.46M |
Total Liabilities | $3.44M | $3.19M | $16.64M | $25.67M |
Cash & Equivalents | $24.36M | $4.36M | $1.16M | $654.00K |
Free Cash Flow OCF − CapEx | $-9.65M | $-18.23M | $-6.09M | $-4.77M |
Shares Outstanding | 80.30M | 30.53M | 11.96M | 5.29M |